10 FAQs on Prescription Drug Importation
Some examples of these proposals introduced in the 116th Congress are H.R.4 47/ S. 97, “Affordable and Safe Prescription Drug Importation Act,” sponsored by the late Representative Elijah Cummings (D-MD) in the House and Senator Bernie Sanders (I-VT) in the Senate, available at: https://www.congress.gov/116/bills/hr447/BILLS-116hr447ih.pdf; https://www.congress.gov/116/bills/s97/BILLS-116s97is.pdf; H. R. 478/ S. 61, “Safe and Affordable Drugs from Canada Act of 2019,” sponsored by Representative Chellie Pingree (D-ME) and Senator Chuck Grassley (R-IA) available at: https://www.congress.gov/116/bills/hr478/BILLS-116hr478ih.pdf; https://www.congress.gov/116/bills/s61/BILLS-116s61is.pdf
A drug manufactured in the U.S., then exported abroad, can be imported back into the U.S. under two circumstances: 1) by the HHS Secretary for emergency medical purposes; and 2) by the original manufacturer of the drug. A manufacturer may choose to do this in a situation where a drug has been recalled or damaged or for other standard inventory control practices. See https://www.finance.senate.gov/imo/media/doc/srpt100-303.pdf
In its comment letter, APhA says they submitted comments jointly with seven major pharmacy organizations: American Pharmacists Association, American Society of Health-System Pharmacists, Academy of Managed Care Pharmacy, National Community Pharmacy Association, National Alliance of State Pharmacy Associations, American Society of Consulting Pharmacists, College of Psychiatric and Neurologic Pharmacist.